Table 1:
Patient Characteristics
| Characteristics | No. of patients (%) |
|---|---|
| Total no. of evaluable patients | 32 |
| Age (median, range) | 65.5(40,83) |
| Sex | |
| Male | 14 (44%) |
| Female | 18 (56%) |
| Race | |
| White | 30 (100%) |
| Unknown | 2 |
| Ethnicity | |
| Hispanic | 2 (7%) |
| Non-Hispanic | 28 (93%) |
| Unknown | 2 |
| ECOG PS | |
| 0 | 6 (19%) |
| 1 | 26 (81%) |
| No. of prior therapies | |
| 1 | 6 (19%) |
| 2 | 4 (12%) |
| 3 | 4 (12%) |
| >3 | 18 (56%) |
| Weight loss in previous 6 months | |
| < 5% | 26 (81%) |
| 5 to < 10% | 4 (12%) |
| 10 to < 20% | 3 (6%) |
| Tumor Histology | |
| Gastrointestinal | 8 (25%) |
| Adenocarcinoma of colon | 6 |
| Adenocarcinoma of rectum | 1 |
| Intrahepatic cholangiocarcinoma | 1 |
| Gynecologic | 4 (12%) |
| Serous adenocarcinoma of ovary | 1 |
| Malignant mixed Mullerian tumor of uterus | 1 |
| Endometrioid endometrial adenocarcinoma | 1 |
| Melanoma of vulva | 1 |
| Breast (ductal carcinoma) | 1 (3%) |
| Lung adenocarcinoma | 9 (28%) |
| Adenocarcinoma | 6 |
| Adenosquamous carcinoma | 1 |
| Hepatoid adenocarcinoma | 1 |
| Sarcomatoid adenocarcinoma | 1 |
| Genitourinary | 5 (16%) |
| Prostate adenocarcinoma | 1 |
| Prostate adenocarcinoma with neuroendocrine differentiation | 3 |
| Osteosarcoma of the renal pelvis | 1 |
| Lymphoma | 2 (6%) |
| Cutaneous T-cell anaplastic large cell lymphoma | 1 |
| Diffuse large B-cell lymphoma | 1 |
| Spindle cell component of parotid epithelial- myoepithelial carcinoma | 1 |
| Adenocarcinoma of unknown primary site | 2 (6%) |